Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
about
Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and childrenHeparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adultsHeparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and childrenEffectiveness of heparin versus 0.9% saline solution in maintaining the permeability of central venous catheters: a systematic reviewNormal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysisFocus on peripherally inserted central catheters in critically ill patientsComparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous catheters.Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit.Randomized controlled trials in central vascular access devices: A scoping reviewVenous Access Devices: Clinical Rounds.Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine.Central Venous Catheter Flushing Recommendations: A Systematic Evidence-Based Practice Review.Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee.[Heparin for clearance of peripherally inserted central venous catheter in newborns: an in vitro study].Survival analysis in the presence of competing risks.
P2860
Q24187703-695EB7C0-091E-40E7-92B5-D18632821040Q24193149-83B46BBB-CB00-4F89-8184-3E48C306C760Q24200751-2C91119E-AF06-4F3B-85D4-8721715FE809Q28078471-69208AB8-DDB5-416A-81A4-888121BDCEC0Q33438241-C303D682-6FC5-4DDB-A42E-B1B2B11762EDQ34452364-B05073B4-CB2E-4B57-98C0-29C3532EA00DQ35310153-E6B35BAC-A7FF-4099-977B-04170FE1B527Q35657030-B4FC903F-401A-4659-AD43-36EA32759F3FQ36316517-BF04717D-B71D-408C-887E-5D4D2D40B732Q37559441-9026A7DA-5D08-401E-908F-9C1491661093Q38193213-D7F156AE-0E05-429D-9293-88B42B90617EQ38209257-586EACD4-1B6D-4533-A771-EA08D381E765Q40112919-0A10FD6B-3D18-4B89-9C41-E27F41E6CB4FQ41993661-5F800802-ECCE-47C8-9973-A252223A9F66Q42319832-FE7FD1B5-9E62-409E-8BFE-9D542A027311
P2860
Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Heparin or 0.9% sodium chlorid ...... r patency: a randomized trial.
@ast
Heparin or 0.9% sodium chlorid ...... r patency: a randomized trial.
@en
type
label
Heparin or 0.9% sodium chlorid ...... r patency: a randomized trial.
@ast
Heparin or 0.9% sodium chlorid ...... r patency: a randomized trial.
@en
prefLabel
Heparin or 0.9% sodium chlorid ...... r patency: a randomized trial.
@ast
Heparin or 0.9% sodium chlorid ...... r patency: a randomized trial.
@en
P2093
P1476
Heparin or 0.9% sodium chlorid ...... r patency: a randomized trial.
@en
P2093
Carrie Sona
Donna Prentice
Lee P Skrupky
Marilyn E Schallom
Scott T Micek
P304
P356
10.1097/CCM.0B013E31824E11B4
P407
P577
2012-06-01T00:00:00Z